Reliance Pharma Fund
Unrated
Value Research
0.13%
Change from previous, NAV as on Apr 22, 2014
Category: Equity: Pharma
Assets: R 803 crore (As on Mar 31, 2014)
Expense: 2.65% (As on Sep 30, 2013)
Investment Objective

The scheme seeks to generate consistent returns by investing in equity / equity related or fixed income securities of pharma and other associated companies.

Fund Managers

Sailesh Raj Bhan since Mar 2005